Phase I Clinical Trial With Pharmacokinetic and Pharmacodynamic Determination of Subcutaneous Pegfilgrastim in Healthy Subjects
Latest Information Update: 20 Aug 2024
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Megalabs
- 16 Aug 2024 Status changed from recruiting to completed.
- 08 Apr 2022 Planned End Date changed from 1 Jun 2022 to 18 Sep 2022.
- 08 Apr 2022 Planned primary completion date changed from 1 Sep 2021 to 18 Aug 2022.